Eli Lilly and Co.’s Ebglyss (lebrikizumab) becomes the latest U.S. entrant in the increasingly competitive atopic dermatitis space, following FDA approval of the IL-13-targeting antibody, which will ...

In “Kingmaker,” Sonia Purnell revisits the life, and many loves, of a Brit who energized dispirited Democrats in the age of ...

It’s been 50 years since the publication of The Power Broker, Robert Caro’s magisterial biography of New York City master builder Robert Moses. Indeed, The Power Broker is a spellbinding ...

How many Broadway shows has George Abbott been in? George Abbott has appeared on Broadway in 13 shows. How many West End shows has George Abbott been in? George Abbott has not appeared in the West ...

Eli Lilly is still celebrating the FDA approval ... including Eisai's antibody-based E-2814 and small-molecule drugs from Annovis Bio (buntanetap), BioVie (bezisterim), and TauRx (HMTM).

Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for the treatment of adults and ...

for What the Constitution Means to Me - Pulitzer Prize for Drama (The Pulitzer Prize) for What the Constitution Means to Me - Best Performance by an Actress in a Leading Role in a Play (Tony ...

FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra. Novo Nordisk’s American depositary receipts tumbled almost 6% ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...

She has been a member of three Pulitzer-prize winning teams at The Post, including in 2022 for an investigation of the Jan. 6 assault on the U.S. Capitol, in 2018 for digging into Moscow’s ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles ...